8-K/A: Ultralife Corp. Completes Acquisition of Electrochem Solutions, Inc., Financials Released
Acquisition Financials
Ultralife Corporation has acquired Electrochem Solutions, Inc., and the associated financial statements have been released in an amended 8-K filing.
Summary
- Ultralife Corporation acquired Electrochem Solutions, Inc. on October 31, 2024, for $48 million in cash.
- This amended 8-K filing includes audited financial statements for Electrochem as of December 31, 2023, and unaudited financials as of September 27, 2024.
- Pro forma combined financial information is provided as if the acquisition occurred on January 1, 2023, for the income statements and September 30, 2024, for the balance sheet.
- Electrochem's 2023 revenue was $42.9 million with a net income of $1.376 million.
- For the nine months ended September 27, 2024, Electrochem's revenue was $25.182 million with a net loss of $263 thousand.
- The pro forma combined financials include adjustments for the acquisition, such as the fair value of assets and liabilities.
Sentiment
Score: 6
Explanation: The document presents a mixed picture with a profitable 2023 for Electrochem but a loss in the first nine months of 2024. The acquisition is a positive move for Ultralife, but the integration and financial adjustments introduce some uncertainty.
Positives
- The acquisition of Electrochem expands Ultralife's business operations.
- Electrochem had a profitable year in 2023 with a net income of $1.376 million.
- The pro forma combined financials show a positive net income for both the nine-month period ended September 30, 2024, and the year ended December 31, 2023.
Negatives
- Electrochem experienced a net loss of $263 thousand for the nine months ended September 27, 2024.
- The pro forma combined financials include significant adjustments, indicating a complex integration process.
- The pro forma financials are not necessarily indicative of future performance.
Risks
- The pro forma financial information is for informational purposes only and may not reflect actual future results.
- The final purchase price allocation is subject to change, which could impact the reported financials.
- The integration of Electrochem into Ultralife may present unforeseen challenges.
- A significant portion of Electrochem's sales and accounts receivable are concentrated with a single customer, creating a credit risk.
Future Outlook
The pro forma combined financial information is for informational purposes only and should not be considered indicative of future results.
Industry Context
The acquisition of Electrochem by Ultralife is a strategic move to expand Ultralife's presence in the battery solutions market, potentially increasing its competitiveness against other players in the industry.
Comparison to Industry Standards
- It is difficult to make a direct comparison to industry standards without knowing the specific market segments Electrochem and Ultralife operate in.
- However, the pro forma combined financials show a positive net income, which is a positive sign compared to companies that are not profitable.
- The acquisition price of $48 million is a significant investment, which suggests that Ultralife sees strong potential in Electrochem's business.
- The concentration of sales with one customer is a risk that is not uncommon in the industry, but it is something that Ultralife will need to manage.
Stakeholder Impact
- Shareholders of Ultralife will see an expansion of the company's business.
- Employees of Electrochem will become part of Ultralife.
- Customers of both companies may see changes in product offerings and services.
- Suppliers of both companies may see changes in their business relationships.
Next Steps
- Ultralife will need to integrate Electrochem's operations and financials.
- The final purchase price allocation will need to be completed.
- The company will need to manage the credit risk associated with the concentration of sales with one customer.
Key Dates
| Date | Description |
|---|---|
| December 31, 2023 | Electrochem's audited combined financial statements year end. |
| January 1, 2023 | Pro forma combined income statements assume the acquisition occurred on this date. |
| September 27, 2024 | Electrochem's unaudited combined financial statements nine-month period end. |
| September 30, 2024 | Pro forma combined balance sheet assumes the acquisition occurred on this date. |
| October 31, 2024 | Ultralife Corporation completed the acquisition of Electrochem Solutions, Inc. |
| January 16, 2025 | Date of the independent auditor's consent and the date the financial statements were available to be issued. |
Keywords
acquisition, financial statements, pro forma, Electrochem Solutions, Ultralife Corporation, carve-out, battery solutions, merger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.